Announcements

Job offersmore »

Tweeting Growers

Top 5 - yesterday

Top 5 - last week

Top 5 - last month

Exchange ratesmore »




CAN (ON): Aphria inks wholesale supply deal with Scientus Pharma

Aphria, through its subsidiary Pure Natures Wellness, entered into a major wholesale supply agreement with HydRx Farms. Under the terms of the Agreement, Aphria is committing to supply over 25,000 fully grown medical cannabis plants over the next 12 months to Scientus Pharma. The first delivery, under the agreement will occur in the middle of Aphria’s second quarter of 2018. Aphria expects to generate over $1.2 million of revenue from the wholesale supply agreement in each full quarter of
shipments, with gross margins consistent with previously executed wholesale agreements.



Scientus Pharma, a vertically-integrated biopharmaceutical company, is raising the bar of cannabinoid products from medical-grade to pharmaceutical-grade. Leveraging its proprietary, patent-pending formulation and processing technologies, Scientus Pharma is committed to leading the medical cannabis market towards pharmaceutical standards in manufacturing, formulations and dosing.

“Scientus Pharma shares our vision for providing high-quality products to medical cannabis patients, which is enabled by our 509-step Seed-to Sale quality assurance program,” said Vic Neufeld, Chief Executive Officer of Aphria. “Through this agreement, Scientus Pharma will get access to clean and safe cannabis, which is necessary in the biopharmaceutical cannabis industry. In return, Aphria will benefit from guaranteed product distribution advancing Aphria’s growth strategy.”

“Scientus Pharm intends to leverage this key raw material supply contract to help it lead the evolution of cannabinoid products from medical-grade to pharmaceutical-grade,” said Trevor Folk, Chief Executive Officer of Scientus Pharma. “Our proprietary extraction technology platform has solved the resin consistency issue that has here-to-for prevented that scientific advancement, and it is the foundation for Scientus Pharma’s pipeline of novel products.”

For more information:
Aphria Inc.
Vic Neufeld
President & CEO
1-844-427-4742
aphria.com

Scientus Pharma
209 Dundas St. E
PO Box 31 Whitby
Whitby, ON L1N 5R7
T: +1 844 493.7922
info@scientuspharma.com
scientuspharma.com

Publication date: 7/6/2017

 


 

Other news in this sector:

7/21/2017 Canada’s premiers discuss delaying MJ legalization
7/21/2017 Australia: The Hydroponics Company granted cannabis research licence
7/21/2017 US: Puration acquires 25-greenhouse grow operation
7/20/2017 Canadian firm invests in African MMJ cultivation
7/20/2017 CAN (BC): Nicolas Elbaze joins Sublime team
7/20/2017 US (CO): Grower optimizes cannabis operation for hot climate
7/20/2017 US (CA): Do's and don'ts of cannabis and crop protection
7/19/2017 US (WA): MCOA receives funding for 30,000 sq. ft. greenhouse
7/19/2017 Uruguay legalizes over-the-counter cannabis sales
7/18/2017 US states say 'yes' to MMJ, federal govt says 'no'
7/18/2017 US: Hawaii's MMJ industry not getting off the ground
7/17/2017 Australia: Victorian minister finds MMJ inspiration in Canada and Israel
7/14/2017 Greece legalises marijuana for medical purposes
7/14/2017 Puerto Rico enacts medicinal marijuana law
7/14/2017 US (AR): No applications yet for MMJ cultivation
7/13/2017 US (NV): Two more recreational MJ licenses for Marapharm
7/13/2017 CAN (ON): Former rose farm becomes MMJ operation
7/13/2017 CAN (ON): Police monitoring marijuana grow-op at former flowers greenhouse
7/12/2017 US (AZ): Merger creates large Arizona MMJ farm
7/11/2017 US (NV): 'State of emergency' due to marijuana shortage